Mutant prevention concentrations of tetracycline, rifampicin and ciprofloxacin for Brucellae melitensis.
Coban
A Y
AY
Tanyel
E
E
Tasdelen Fisgin
N
N
Darka
O
O
Tulek
N
N
Durupinar
B
B
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D017347:Brucella melitensis / Q000187:drug effects*; D002006:Brucellosis / Q000188:drug therapy; D002939:Ciprofloxacin / Q000494:pharmacology*; D004359:Drug Therapy, Combination; D006801:Humans; D008826:Microbial Sensitivity Tests; D009154:Mutation; D012293:Rifampin / Q000494:pharmacology*; D013752:Tetracycline / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D013752:Tetracycline; D012293:Rifampin